Johnson & Johnson ordered to pay $417M in trial over talc cancer risks

A California jury on Monday ordered Johnson & Johnson to pay $417 million US to a woman who claimed she developed ovarian cancer after using the company's talc-based products.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news